Diseases & Disorders
(G500)
DX Registered
990 on File
AMYOTROPHIC LATERAL SCLEROSIS ASSN
Financial strength (30%)
61/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$68.6M
Total Revenue
$82.2M
Total Expenses
$89.0M
Net Assets
528
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
68.7%
Fundraising Efficiency
1329.3%
Operating Reserve
12.98x
Liability-to-Asset
17.0%
Revenue Diversification
96.0%
Executive Compensation
$2.5M
Compared with Peers
FY 2025
Compared with 77 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
68.7% | 85.3% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.2% | 11.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
23.1% | 0.8% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
1329.3% | 350.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.0 mo | 9.7 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
17.0% | 20.6% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.0% | 92.8% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-45.8% | 8.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-16.8% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-19.9% | 2.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $68.6M | $82.2M | $89.0M | 68.7% | 528 |
| 2024 | $126.5M | $98.8M | $98.1M | 66.7% | 598 |
| 2023 | $55.6M | $84.2M | $64.2M | 63.1% | 547 |
| 2022 | $39.8M | $44.9M | N/A | — | 151 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.